Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease

Journal of Neural Transmission

Volumn 117, Issue 12, 2010, Pages 1395-1399

  Giladi, Nir ^c   Fichtner, Andreas ^a   Poewe, Werner ^b   Boroojerdi, Babak ^a  

^a Schwarz Pharma AG   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c NONE

Author keywords

Dopamine agonist; Early morning akinesia; Parkinson's disease; Rotigotine transdermal patch; Sleep disorders

Indexed keywords

AMANTADINE; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; ROTIGOTINE;

AGED; AKINESIA; APPLICATION SITE REACTION; ARTICLE; DAYTIME SOMNOLENCE; DISEASE CONTROL; DRUG DOSE TITRATION; DRUG EFFICACY; DYSTONIA; EARLY MORNING MOTOR IMPAIRMENT; FEMALE; HOSPITALIZATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MOTOR DYSFUNCTION; MULTICENTER STUDY; NAUSEA; NOCTURIA; OPEN STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP; SLEEP DISORDER; SOMNOLENCE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSON DISEASE; PROSPECTIVE STUDIES; SLEEP DISORDERS; TETRAHYDRONAPHTHALENES; THIOPHENES;

EID: 78651251697     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0506-4     Document Type: Article

References (19)

1. A Abdelgabar J Sharma 2003 Sleep disorders in Parkinson's disease Int J Clin Pract 57 781 787 1:STN:280:DC%2BD3sngsVSmtg%3D%3D 14686569
2. B Aranda P Cramer 1993 Effect of apomorphine and l-dopa on the parkinsonian bladder Neurourol Urodyn 12 3 203 209 1:CAS:528:DyaK3sXlvFGnur0%3D 10.1002/nau.1930120302 8330043 (Pubitemid 23160774)
3. S Chapuis L Ouchchane O Metz L Gerbaud F Durif 2005 Impact of the motor complications of Parkinson's disease on the quality of life Mov Disord 20 224 230 10.1002/mds.20279 15384126 (Pubitemid 40361128)
4. TN Chase 1998 The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease Drugs 55 1 9 10.2165/00003495-199855001- 00001 9483164
5. KR Chaudhuri S Pal A DiMarco C Whately-Smith K Bridgman R Mathew FR Pezzela A Forbes B Hogl C Trenkwalder 2002 The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease J Neurol Neurosurg Psychiatry 73 629 635 1:STN:280: DC%2BD38jhs1Gkuw%3D%3D 10.1136/jnnp.73.6.629 12438461 (Pubitemid 35448845)
6. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease, vol 2. MacMillan Healthcare Information, Florham Park, pp 153-163
7. N Giladi B Boroojerdi AD Korczyn DJ Burn CE Clarke AH Schapira 2007 Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole Mov Disord 22 2398 2404 10.1002/mds.21741 17935234 (Pubitemid 351155987)
8. J Herzog PH Weiss A Assmus B Wefer C Seif PM Braun H Herzog J Volkmann G Deuschl GR Fink 2006 Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease Brain 129 3366 3375 10.1093/brain/awl302 17077105 (Pubitemid 44871449)
9. B Högl A Rothdach TC Wetter C Trenkwalder 2003 The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease Neuropsychopharmacology 28 1866 1870 10.1038/sj.npp.1300250 12865895 (Pubitemid 41070852)
10. MW Johns 1991 A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 540 545 1:STN:280:DyaK387ovVSksw%3D%3D 1798888
11. JW Langston H Widner CG Goetz D Brooks S Fahn T Freeman R Watts 1992 Core assessment program for intracerebral transplantations (CAPIT) Mov Disord 7 2 13 1:STN:280:DyaK383ht1egsA%3D%3D 10.1002/mds.870070103 1557062
12. AJ Lees NA Blackburn VL Campbell 1988 The nighttime problems of Parkinson's disease Clin Neuropharmacol 11 512 519 1:STN:280: DyaL1M7mvVantg%3D%3D 10.1097/00002826-198812000-00004 3233589
13. S Morris ME Morris R Lansek 2001 Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease Phys Ther 81 810 818 1:STN:280:DC%2BD3M7otVWruw%3D%3D 11175678
14. WH Poewe O Rascol N Quinn E Tolosa WH Oertel E Martignoni M Rupp B Boroojerdi 2007 Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial Lancet Neurol 6 513 520 1:CAS:528:DC%2BD2sXmslKktr8%3D 10.1016/S1474-4422(07) 70108-4 17509486 (Pubitemid 46734759)
15. MR Pressman WG Figueroa J Kendrick-Mohamed LW Greenspon DD Peterson 1996 Nocturia. A rarely recognized symptom of sleep apnea and other occult sleep disorders Arch Intern Med 156 5 545 550 1:STN:280:DyaK287nvV2juw%3D%3D 10.1001/archinte.156.5.545 8604961 (Pubitemid 26077357)
16. I Reuter CM Ellis K Ray Chaudhuri 1999 Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome Acta Neurol Scand 100 163 167 1:CAS:528:DyaK1MXlvVKgtbg%3D 10.1111/j.1600-0404.1999.tb00732.x 10478579
17. F Stocchi L Barbato G Nordera A Berardelli S Ruggieri 1998 Sleep disorders in Parkinson's disease J Neurol 245 S15 S18 10.1007/PL00007731 9617717
18. Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR, RECOVER study group (2010) Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord (in press)
19. RL Watts J Jankovic C Waters A Rajput B Boroojerdi J Rao 2007 Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease Neurology 68 272 276 1:CAS:528:DC%2BD2sXlt12msg%3D%3D 10.1212/01.wnl.0000252355. 79284.22 17202432 (Pubitemid 46148338)